SUBSCRIBE
SUBSCRIBE
News   Business

Ipsen’s First Half 2006 Results

September 6, 2006 | 
1 min read
PARIS--(BUSINESS WIRE)--Sept. 6, 2006--Ipsen (Paris: IPN) -- Results in line with expectations: annual objectives maintained -- Strong cash-flow generation during the period: EUR 130 million
Earnings Europe
Ipsen Biopharmaceuticals, Inc.
MORE ON THIS TOPIC
Trendy halftone collage. A hand holds a ringing alarm clock. Time, hurry up. Vector business concepts for graphic and web design, marketing and print materials, social media. Vector illustration
Regulatory
Two FDA Decisions for Regeneron’s Eylea HD Delayed Into Q4
August 21, 2025
 · 
2 min read
 · 
Tristan Manalac
Arrows lead to a graph of a downward trend, then c
Layoffs
CSL Overhauls Business With Vaccine Spinout, 15% Layoffs
August 20, 2025
 · 
1 min read
 · 
Tristan Manalac
Podcast
MAHA Report Emphasizes Vaccines, Safety Vexes Viking’s Obesity Win, Novo Gains Momentum
August 20, 2025
 · 
2 min read
 · 
Heather McKenzie
Contemporary art collage. Businessmen, employees walking into open door symbolizing new opportunities. Way to success. Concept of business, promotion, motivation, ambitions and ideas
Immuno-oncology
Genentech Walks Away From $2B Partnership With Adaptive Biotechnologies
August 19, 2025
 · 
1 min read
 · 
Tristan Manalac